BioSpace News Archive

Genetown

Morphic to Present at 2022 Jefferies Global Healthcare Conference

Morphic Therapeutic announced that Bruce Rogers, Ph.D., President of Morphic, will give a corporate presentation at the Jefferies Global Healthcare Conference on Thursday, June 9th at 2:00 PM ET.

June 9, 2022
·
1 min read
1000 times intestinal survival rate...COSMAX NBT commercializes ‘Zeta Probiotics™' Technology

COSMAX Group has succeeded in developing and commercializing a technology that dramatically increased the intestinal survival rate of lactic acid bacteria.

June 9, 2022
·
2 min read
BioMidwest

Zynex Announces Additional Share Buyback Program - June 09, 2022

Zynex, Inc. announced that its board of directors approved a program to buy back $10.0 million of the Company’s common stock.

June 9, 2022
·
4 min read
Isotopia and CPDC Successfully Deliver First Doses of n.c.a. Lu-177 to North American Customers

Isotopia Molecular Imaging and the Centre for Probe Development and Commercialization (CPDC) announced that Isotopia’s technology for the production of n.c.a. Lu-177 has been successfully transferred into CPDC’s GMP facility and that CPDC has shipped its first doses of commercial n.c.a. Lu-177.

June 9, 2022
·
3 min read
Nova Mentis and University of Central Florida to Develop Saliva Serotonin Assay

Dr. Kiminobu Sugaya, a Professor and Head of Neuroscience in the Burnett School of Biomedical Science at UCF, will measure serotonin levels in the saliva samples collected as part of the recently launched NOVA autism spectrum disorder (ASD) observational study.

June 9, 2022
·
4 min read
Business

Tempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing

Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed to provide broader access to genomic testing to patients with advanced/metastatic non-small cell lung cancer (NSCLC).

June 9, 2022
·
2 min read
Biochips Market Demand 2022-2030: Increasing Adoption of Biochips for Detecting and Testing Allergens Is Expected to Drive Revenue Growth

The Biochips industry report emphasizes the current and upcoming market revenue growth opportunities and trends.

June 9, 2022
·
6 min read
Colchicine Market Growth 2022-2030: Increasing Clinical Studies of Colchicine Drugs for Various Applications

The global colchicine market size is expected to reach USD 2,552.84 Million in 2030 and register a revenue CAGR of 8.4%, according to the latest report by Reports and Data.

June 9, 2022
·
6 min read
Heart Attack Diagnostics Market 2022-2030: Increasing Technological Advancements in Cardiovascular Diagnostics Are Key Factors Driving Industry Revenue Growth

The global heart attack diagnostics market size is expected to reach USD 224.65 Billion in 2030 and register a CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data.

June 9, 2022
·
7 min read
Pharm Country

Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient

Tiziana Life Sciences PLC announced positive clinical results for its second secondary progressive multiple sclerosis patient in a June 8th press release.

June 9, 2022
·
9 min read